Increased levels of SPARC were associated with lymph node metastasis in colorectal and oesophageal cancers, liver metastasis in colorectal cancer and bone metastasis in prostate cancers (Porte et al, 1995; Thomas et al, 2000; Yamashita et al, 2003). The gene discussed is SPARC; the disease is prostate carcinoma.